Global Microbiome Therapeutics Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Microbiome Therapeutics market size is predicted to grow from US$ 169 million in 2025 to US$ 1246 million in 2031; it is expected to grow at a CAGR of 39.5% from 2025 to 2031.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI is about 52%.
For Microbiome Therapeutics Pipeline Product, SER-109, ABI-H0731, ribaxamase, SYN-010 have the most investment in research, there are in Phase 3, PHASE 1b and Phase 2.
North American is the largest market, It occupy nearly 37% market share. Following North American, Europe is the second largest market with the consumption market share of 30%.
Market competition is not intense. Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech are the leading Developers in the industry, with about 60% market shares.
LPI (LP Information)' newest research report, the “Microbiome Therapeutics Industry Forecast” looks at past sales and reviews total world Microbiome Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbiome Therapeutics sales for 2025 through 2031. With Microbiome Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiome Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Microbiome Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbiome Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbiome Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiome Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiome Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Microbiome Therapeutics market size is predicted to grow from US$ 169 million in 2025 to US$ 1246 million in 2031; it is expected to grow at a CAGR of 39.5% from 2025 to 2031.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Application of Microbiome Therapeutics includes CDI, IBD, Orphan Drug, Immuno-oncology and Others, and the proportion of R&D Investmen for CDI is about 52%.
For Microbiome Therapeutics Pipeline Product, SER-109, ABI-H0731, ribaxamase, SYN-010 have the most investment in research, there are in Phase 3, PHASE 1b and Phase 2.
North American is the largest market, It occupy nearly 37% market share. Following North American, Europe is the second largest market with the consumption market share of 30%.
Market competition is not intense. Seres Therapeutics, Assembly Biosciences, Synthetic Biologics, Interxon and PureTech are the leading Developers in the industry, with about 60% market shares.
LPI (LP Information)' newest research report, the “Microbiome Therapeutics Industry Forecast” looks at past sales and reviews total world Microbiome Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbiome Therapeutics sales for 2025 through 2031. With Microbiome Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiome Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Microbiome Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbiome Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbiome Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiome Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiome Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Microbiome Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Upper GIT
- Lower GIT
- C. difficile Infection (CDI)
- Inflammatory Bowel Disease (IBD)
- Orphan Drug
- Immuno-oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seres Therapeutics
- Assembly Biosciences
- Synthetic Biologics
- Interxon
- PureTech
- Synlogic
- Enterome BioScience
- 4D Pharma
- Second Genome
- AOBiome
- C3 Jian
- Rebiotix
- MicroBiome Therapeutics LLC
- Metabiomics
- Ritter Pharmaceuticals
- Symberix
- OpenBiome
- Azitra
- Symbiotix Biotherapies
- Osel
- Metabogen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Market Size (2020-2031)
2.1.2 Microbiome Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Microbiome Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Upper GIT
2.2.2 Lower GIT
2.3 Microbiome Therapeutics Market Size by Type
2.3.1 Microbiome Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Microbiome Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 C. difficile Infection (CDI)
2.4.2 Inflammatory Bowel Disease (IBD)
2.4.3 Orphan Drug
2.4.4 Immuno-oncology
2.4.5 Others
2.5 Microbiome Therapeutics Market Size by Application
2.5.1 Microbiome Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Microbiome Therapeutics Market Size Market Share by Application (2020-2025)
3 MICROBIOME THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Microbiome Therapeutics Market Size Market Share by Player
3.1.1 Global Microbiome Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Microbiome Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS BY REGION
4.1 Microbiome Therapeutics Market Size by Region (2020-2025)
4.2 Global Microbiome Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microbiome Therapeutics Market Size Growth (2020-2025)
4.4 APAC Microbiome Therapeutics Market Size Growth (2020-2025)
4.5 Europe Microbiome Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Microbiome Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Microbiome Therapeutics Market Size by Country (2020-2025)
5.2 Americas Microbiome Therapeutics Market Size by Type (2020-2025)
5.3 Americas Microbiome Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiome Therapeutics Market Size by Region (2020-2025)
6.2 APAC Microbiome Therapeutics Market Size by Type (2020-2025)
6.3 APAC Microbiome Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microbiome Therapeutics Market Size by Country (2020-2025)
7.2 Europe Microbiome Therapeutics Market Size by Type (2020-2025)
7.3 Europe Microbiome Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST
10.1 Global Microbiome Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Microbiome Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Microbiome Therapeutics Forecast
10.1.3 APAC Microbiome Therapeutics Forecast
10.1.4 Europe Microbiome Therapeutics Forecast
10.1.5 Middle East & Africa Microbiome Therapeutics Forecast
10.2 Americas Microbiome Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Microbiome Therapeutics Forecast
10.2.2 Canada Market Microbiome Therapeutics Forecast
10.2.3 Mexico Market Microbiome Therapeutics Forecast
10.2.4 Brazil Market Microbiome Therapeutics Forecast
10.3 APAC Microbiome Therapeutics Forecast by Region (2026-2031)
10.3.1 China Microbiome Therapeutics Market Forecast
10.3.2 Japan Market Microbiome Therapeutics Forecast
10.3.3 Korea Market Microbiome Therapeutics Forecast
10.3.4 Southeast Asia Market Microbiome Therapeutics Forecast
10.3.5 India Market Microbiome Therapeutics Forecast
10.3.6 Australia Market Microbiome Therapeutics Forecast
10.4 Europe Microbiome Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Microbiome Therapeutics Forecast
10.4.2 France Market Microbiome Therapeutics Forecast
10.4.3 UK Market Microbiome Therapeutics Forecast
10.4.4 Italy Market Microbiome Therapeutics Forecast
10.4.5 Russia Market Microbiome Therapeutics Forecast
10.5 Middle East & Africa Microbiome Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Microbiome Therapeutics Forecast
10.5.2 South Africa Market Microbiome Therapeutics Forecast
10.5.3 Israel Market Microbiome Therapeutics Forecast
10.5.4 Turkey Market Microbiome Therapeutics Forecast
10.6 Global Microbiome Therapeutics Forecast by Type (2026-2031)
10.7 Global Microbiome Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Microbiome Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Information
11.1.2 Seres Therapeutics Microbiome Therapeutics Product Offered
11.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Seres Therapeutics Main Business Overview
11.1.5 Seres Therapeutics Latest Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Information
11.2.2 Assembly Biosciences Microbiome Therapeutics Product Offered
11.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Assembly Biosciences Main Business Overview
11.2.5 Assembly Biosciences Latest Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Information
11.3.2 Synthetic Biologics Microbiome Therapeutics Product Offered
11.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Synthetic Biologics Main Business Overview
11.3.5 Synthetic Biologics Latest Developments
11.4 Interxon
11.4.1 Interxon Company Information
11.4.2 Interxon Microbiome Therapeutics Product Offered
11.4.3 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Interxon Main Business Overview
11.4.5 Interxon Latest Developments
11.5 PureTech
11.5.1 PureTech Company Information
11.5.2 PureTech Microbiome Therapeutics Product Offered
11.5.3 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PureTech Main Business Overview
11.5.5 PureTech Latest Developments
11.6 Synlogic
11.6.1 Synlogic Company Information
11.6.2 Synlogic Microbiome Therapeutics Product Offered
11.6.3 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Synlogic Main Business Overview
11.6.5 Synlogic Latest Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Information
11.7.2 Enterome BioScience Microbiome Therapeutics Product Offered
11.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Enterome BioScience Main Business Overview
11.7.5 Enterome BioScience Latest Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Information
11.8.2 4D Pharma Microbiome Therapeutics Product Offered
11.8.3 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 4D Pharma Main Business Overview
11.8.5 4D Pharma Latest Developments
11.9 Second Genome
11.9.1 Second Genome Company Information
11.9.2 Second Genome Microbiome Therapeutics Product Offered
11.9.3 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Second Genome Main Business Overview
11.9.5 Second Genome Latest Developments
11.10 AOBiome
11.10.1 AOBiome Company Information
11.10.2 AOBiome Microbiome Therapeutics Product Offered
11.10.3 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AOBiome Main Business Overview
11.10.5 AOBiome Latest Developments
11.11 C3 Jian
11.11.1 C3 Jian Company Information
11.11.2 C3 Jian Microbiome Therapeutics Product Offered
11.11.3 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 C3 Jian Main Business Overview
11.11.5 C3 Jian Latest Developments
11.12 Rebiotix
11.12.1 Rebiotix Company Information
11.12.2 Rebiotix Microbiome Therapeutics Product Offered
11.12.3 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Rebiotix Main Business Overview
11.12.5 Rebiotix Latest Developments
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Information
11.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 MicroBiome Therapeutics LLC Main Business Overview
11.13.5 MicroBiome Therapeutics LLC Latest Developments
11.14 Metabiomics
11.14.1 Metabiomics Company Information
11.14.2 Metabiomics Microbiome Therapeutics Product Offered
11.14.3 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Metabiomics Main Business Overview
11.14.5 Metabiomics Latest Developments
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Information
11.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ritter Pharmaceuticals Main Business Overview
11.15.5 Ritter Pharmaceuticals Latest Developments
11.16 Symberix
11.16.1 Symberix Company Information
11.16.2 Symberix Microbiome Therapeutics Product Offered
11.16.3 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Symberix Main Business Overview
11.16.5 Symberix Latest Developments
11.17 OpenBiome
11.17.1 OpenBiome Company Information
11.17.2 OpenBiome Microbiome Therapeutics Product Offered
11.17.3 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 OpenBiome Main Business Overview
11.17.5 OpenBiome Latest Developments
11.18 Azitra
11.18.1 Azitra Company Information
11.18.2 Azitra Microbiome Therapeutics Product Offered
11.18.3 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Azitra Main Business Overview
11.18.5 Azitra Latest Developments
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Information
11.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Offered
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Symbiotix Biotherapies Main Business Overview
11.19.5 Symbiotix Biotherapies Latest Developments
11.20 Osel
11.20.1 Osel Company Information
11.20.2 Osel Microbiome Therapeutics Product Offered
11.20.3 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Osel Main Business Overview
11.20.5 Osel Latest Developments
11.21 Metabogen
11.21.1 Metabogen Company Information
11.21.2 Metabogen Microbiome Therapeutics Product Offered
11.21.3 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Metabogen Main Business Overview
11.21.5 Metabogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. MicrobiomeTherapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. MicrobiomeTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Upper GIT
Table 4. Major Players of Lower GIT
Table 5. MicrobiomeTherapeutics Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 7. Global MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Table 8. MicrobiomeTherapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global MicrobiomeTherapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global MicrobiomeTherapeutics Revenue Market Share by Player (2020-2025)
Table 13. MicrobiomeTherapeutics Key Players Head office and Products Offered
Table 14. MicrobiomeTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global MicrobiomeTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global MicrobiomeTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas MicrobiomeTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas MicrobiomeTherapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 24. Americas MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Table 25. Americas MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 30. APAC MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe MicrobiomeTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe MicrobiomeTherapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 34. Europe MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of MicrobiomeTherapeutics
Table 39. Key Market Challenges & Risks of MicrobiomeTherapeutics
Table 40. Key IndustryTrends of MicrobiomeTherapeutics
Table 41. Global MicrobiomeTherapeutics Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global MicrobiomeTherapeutics Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global MicrobiomeTherapeutics Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global MicrobiomeTherapeutics Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. SeresTherapeutics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 46. SeresTherapeutics MicrobiomeTherapeutics Product Offered
Table 47. SeresTherapeutics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. SeresTherapeutics Main Business
Table 49. SeresTherapeutics Latest Developments
Table 50. Assembly Biosciences Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 51. Assembly Biosciences MicrobiomeTherapeutics Product Offered
Table 52. Assembly Biosciences MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Assembly Biosciences Main Business
Table 54. Assembly Biosciences Latest Developments
Table 55. Synthetic Biologics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 56. Synthetic Biologics MicrobiomeTherapeutics Product Offered
Table 57. Synthetic Biologics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Synthetic Biologics Main Business
Table 59. Synthetic Biologics Latest Developments
Table 60. Interxon Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 61. Interxon MicrobiomeTherapeutics Product Offered
Table 62. Interxon MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Interxon Main Business
Table 64. Interxon Latest Developments
Table 65. PureTech Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 66. PureTech MicrobiomeTherapeutics Product Offered
Table 67. PureTech MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. PureTech Main Business
Table 69. PureTech Latest Developments
Table 70. Synlogic Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 71. Synlogic MicrobiomeTherapeutics Product Offered
Table 72. Synlogic MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Synlogic Main Business
Table 74. Synlogic Latest Developments
Table 75. Enterome BioScience Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 76. Enterome BioScience MicrobiomeTherapeutics Product Offered
Table 77. Enterome BioScience MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Enterome BioScience Main Business
Table 79. Enterome BioScience Latest Developments
Table 80. 4D Pharma Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 81. 4D Pharma MicrobiomeTherapeutics Product Offered
Table 82. 4D Pharma MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. 4D Pharma Main Business
Table 84. 4D Pharma Latest Developments
Table 85. Second Genome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 86. Second Genome MicrobiomeTherapeutics Product Offered
Table 87. Second Genome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Second Genome Main Business
Table 89. Second Genome Latest Developments
Table 90. AOBiome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 91. AOBiome MicrobiomeTherapeutics Product Offered
Table 92. AOBiome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AOBiome Main Business
Table 94. AOBiome Latest Developments
Table 95. C3 Jian Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 96. C3 Jian MicrobiomeTherapeutics Product Offered
Table 97. C3 Jian MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. C3 Jian Main Business
Table 99. C3 Jian Latest Developments
Table 100. Rebiotix Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 101. Rebiotix MicrobiomeTherapeutics Product Offered
Table 102. Rebiotix MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Rebiotix Main Business
Table 104. Rebiotix Latest Developments
Table 105. MicroBiomeTherapeutics LLC Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 106. MicroBiomeTherapeutics LLC MicrobiomeTherapeutics Product Offered
Table 107. MicroBiomeTherapeutics LLC MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. MicroBiomeTherapeutics LLC Main Business
Table 109. MicroBiomeTherapeutics LLC Latest Developments
Table 110. Metabiomics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 111. Metabiomics MicrobiomeTherapeutics Product Offered
Table 112. Metabiomics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Metabiomics Main Business
Table 114. Metabiomics Latest Developments
Table 115. Ritter Pharmaceuticals Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 116. Ritter Pharmaceuticals MicrobiomeTherapeutics Product Offered
Table 117. Ritter Pharmaceuticals MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Ritter Pharmaceuticals Main Business
Table 119. Ritter Pharmaceuticals Latest Developments
Table 120. Symberix Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 121. Symberix MicrobiomeTherapeutics Product Offered
Table 122. Symberix MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Symberix Main Business
Table 124. Symberix Latest Developments
Table 125. OpenBiome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 126. OpenBiome MicrobiomeTherapeutics Product Offered
Table 127. OpenBiome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. OpenBiome Main Business
Table 129. OpenBiome Latest Developments
Table 130. Azitra Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 131. Azitra MicrobiomeTherapeutics Product Offered
Table 132. Azitra MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Azitra Main Business
Table 134. Azitra Latest Developments
Table 135. Symbiotix Biotherapies Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 136. Symbiotix Biotherapies MicrobiomeTherapeutics Product Offered
Table 137. Symbiotix Biotherapies MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Symbiotix Biotherapies Main Business
Table 139. Symbiotix Biotherapies Latest Developments
Table 140. Osel Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 141. Osel MicrobiomeTherapeutics Product Offered
Table 142. Osel MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Osel Main Business
Table 144. Osel Latest Developments
Table 145. Metabogen Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 146. Metabogen MicrobiomeTherapeutics Product Offered
Table 147. Metabogen MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Metabogen Main Business
Table 149. Metabogen Latest Developments
LIST OFFIGURES
Figure 1. MicrobiomeTherapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global MicrobiomeTherapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. MicrobiomeTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. MicrobiomeTherapeutics Sales Market Share by Country/Region (2024)
Figure 8. MicrobiomeTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global MicrobiomeTherapeutics Market Size Market Share byType in 2024
Figure 10. MicrobiomeTherapeutics in C. difficile Infection (CDI)
Figure 11. Global MicrobiomeTherapeutics Market: C. difficile Infection (CDI) (2020-2025) & ($ millions)
Figure 12. MicrobiomeTherapeutics in Inflammatory Bowel Disease (IBD)
Figure 13. Global MicrobiomeTherapeutics Market: Inflammatory Bowel Disease (IBD) (2020-2025) & ($ millions)
Figure 14. MicrobiomeTherapeutics in Orphan Drug
Figure 15. Global MicrobiomeTherapeutics Market: Orphan Drug (2020-2025) & ($ millions)
Figure 16. MicrobiomeTherapeutics in Immuno-oncology
Figure 17. Global MicrobiomeTherapeutics Market: Immuno-oncology (2020-2025) & ($ millions)
Figure 18. MicrobiomeTherapeutics in Others
Figure 19. Global MicrobiomeTherapeutics Market: Others (2020-2025) & ($ millions)
Figure 20. Global MicrobiomeTherapeutics Market Size Market Share by Application in 2024
Figure 21. Global MicrobiomeTherapeutics Revenue Market Share by Player in 2024
Figure 22. Global MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas MicrobiomeTherapeutics Value Market Share by Country in 2024
Figure 28. United States MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC MicrobiomeTherapeutics Market Size Market Share by Region in 2024
Figure 33. APAC MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 34. APAC MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe MicrobiomeTherapeutics Market Size Market Share by Country in 2024
Figure 42. Europe MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 43. Europe MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45.France MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 65. China MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 69. India MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 72.France MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 79.Turkey MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global MicrobiomeTherapeutics Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global MicrobiomeTherapeutics Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Microbiome Therapeutics Market Size (2020-2031)
2.1.2 Microbiome Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Microbiome Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Microbiome Therapeutics Segment by Type
2.2.1 Upper GIT
2.2.2 Lower GIT
2.3 Microbiome Therapeutics Market Size by Type
2.3.1 Microbiome Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Microbiome Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Microbiome Therapeutics Segment by Application
2.4.1 C. difficile Infection (CDI)
2.4.2 Inflammatory Bowel Disease (IBD)
2.4.3 Orphan Drug
2.4.4 Immuno-oncology
2.4.5 Others
2.5 Microbiome Therapeutics Market Size by Application
2.5.1 Microbiome Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Microbiome Therapeutics Market Size Market Share by Application (2020-2025)
3 MICROBIOME THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Microbiome Therapeutics Market Size Market Share by Player
3.1.1 Global Microbiome Therapeutics Revenue by Player (2020-2025)
3.1.2 Global Microbiome Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Microbiome Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS BY REGION
4.1 Microbiome Therapeutics Market Size by Region (2020-2025)
4.2 Global Microbiome Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microbiome Therapeutics Market Size Growth (2020-2025)
4.4 APAC Microbiome Therapeutics Market Size Growth (2020-2025)
4.5 Europe Microbiome Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Microbiome Therapeutics Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Microbiome Therapeutics Market Size by Country (2020-2025)
5.2 Americas Microbiome Therapeutics Market Size by Type (2020-2025)
5.3 Americas Microbiome Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Microbiome Therapeutics Market Size by Region (2020-2025)
6.2 APAC Microbiome Therapeutics Market Size by Type (2020-2025)
6.3 APAC Microbiome Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Microbiome Therapeutics Market Size by Country (2020-2025)
7.2 Europe Microbiome Therapeutics Market Size by Type (2020-2025)
7.3 Europe Microbiome Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Microbiome Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MICROBIOME THERAPEUTICS MARKET FORECAST
10.1 Global Microbiome Therapeutics Forecast by Region (2026-2031)
10.1.1 Global Microbiome Therapeutics Forecast by Region (2026-2031)
10.1.2 Americas Microbiome Therapeutics Forecast
10.1.3 APAC Microbiome Therapeutics Forecast
10.1.4 Europe Microbiome Therapeutics Forecast
10.1.5 Middle East & Africa Microbiome Therapeutics Forecast
10.2 Americas Microbiome Therapeutics Forecast by Country (2026-2031)
10.2.1 United States Market Microbiome Therapeutics Forecast
10.2.2 Canada Market Microbiome Therapeutics Forecast
10.2.3 Mexico Market Microbiome Therapeutics Forecast
10.2.4 Brazil Market Microbiome Therapeutics Forecast
10.3 APAC Microbiome Therapeutics Forecast by Region (2026-2031)
10.3.1 China Microbiome Therapeutics Market Forecast
10.3.2 Japan Market Microbiome Therapeutics Forecast
10.3.3 Korea Market Microbiome Therapeutics Forecast
10.3.4 Southeast Asia Market Microbiome Therapeutics Forecast
10.3.5 India Market Microbiome Therapeutics Forecast
10.3.6 Australia Market Microbiome Therapeutics Forecast
10.4 Europe Microbiome Therapeutics Forecast by Country (2026-2031)
10.4.1 Germany Market Microbiome Therapeutics Forecast
10.4.2 France Market Microbiome Therapeutics Forecast
10.4.3 UK Market Microbiome Therapeutics Forecast
10.4.4 Italy Market Microbiome Therapeutics Forecast
10.4.5 Russia Market Microbiome Therapeutics Forecast
10.5 Middle East & Africa Microbiome Therapeutics Forecast by Region (2026-2031)
10.5.1 Egypt Market Microbiome Therapeutics Forecast
10.5.2 South Africa Market Microbiome Therapeutics Forecast
10.5.3 Israel Market Microbiome Therapeutics Forecast
10.5.4 Turkey Market Microbiome Therapeutics Forecast
10.6 Global Microbiome Therapeutics Forecast by Type (2026-2031)
10.7 Global Microbiome Therapeutics Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Microbiome Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Information
11.1.2 Seres Therapeutics Microbiome Therapeutics Product Offered
11.1.3 Seres Therapeutics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Seres Therapeutics Main Business Overview
11.1.5 Seres Therapeutics Latest Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Information
11.2.2 Assembly Biosciences Microbiome Therapeutics Product Offered
11.2.3 Assembly Biosciences Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Assembly Biosciences Main Business Overview
11.2.5 Assembly Biosciences Latest Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Information
11.3.2 Synthetic Biologics Microbiome Therapeutics Product Offered
11.3.3 Synthetic Biologics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Synthetic Biologics Main Business Overview
11.3.5 Synthetic Biologics Latest Developments
11.4 Interxon
11.4.1 Interxon Company Information
11.4.2 Interxon Microbiome Therapeutics Product Offered
11.4.3 Interxon Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Interxon Main Business Overview
11.4.5 Interxon Latest Developments
11.5 PureTech
11.5.1 PureTech Company Information
11.5.2 PureTech Microbiome Therapeutics Product Offered
11.5.3 PureTech Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 PureTech Main Business Overview
11.5.5 PureTech Latest Developments
11.6 Synlogic
11.6.1 Synlogic Company Information
11.6.2 Synlogic Microbiome Therapeutics Product Offered
11.6.3 Synlogic Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Synlogic Main Business Overview
11.6.5 Synlogic Latest Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Information
11.7.2 Enterome BioScience Microbiome Therapeutics Product Offered
11.7.3 Enterome BioScience Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Enterome BioScience Main Business Overview
11.7.5 Enterome BioScience Latest Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Information
11.8.2 4D Pharma Microbiome Therapeutics Product Offered
11.8.3 4D Pharma Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 4D Pharma Main Business Overview
11.8.5 4D Pharma Latest Developments
11.9 Second Genome
11.9.1 Second Genome Company Information
11.9.2 Second Genome Microbiome Therapeutics Product Offered
11.9.3 Second Genome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Second Genome Main Business Overview
11.9.5 Second Genome Latest Developments
11.10 AOBiome
11.10.1 AOBiome Company Information
11.10.2 AOBiome Microbiome Therapeutics Product Offered
11.10.3 AOBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 AOBiome Main Business Overview
11.10.5 AOBiome Latest Developments
11.11 C3 Jian
11.11.1 C3 Jian Company Information
11.11.2 C3 Jian Microbiome Therapeutics Product Offered
11.11.3 C3 Jian Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 C3 Jian Main Business Overview
11.11.5 C3 Jian Latest Developments
11.12 Rebiotix
11.12.1 Rebiotix Company Information
11.12.2 Rebiotix Microbiome Therapeutics Product Offered
11.12.3 Rebiotix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Rebiotix Main Business Overview
11.12.5 Rebiotix Latest Developments
11.13 MicroBiome Therapeutics LLC
11.13.1 MicroBiome Therapeutics LLC Company Information
11.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Offered
11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 MicroBiome Therapeutics LLC Main Business Overview
11.13.5 MicroBiome Therapeutics LLC Latest Developments
11.14 Metabiomics
11.14.1 Metabiomics Company Information
11.14.2 Metabiomics Microbiome Therapeutics Product Offered
11.14.3 Metabiomics Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Metabiomics Main Business Overview
11.14.5 Metabiomics Latest Developments
11.15 Ritter Pharmaceuticals
11.15.1 Ritter Pharmaceuticals Company Information
11.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Offered
11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Ritter Pharmaceuticals Main Business Overview
11.15.5 Ritter Pharmaceuticals Latest Developments
11.16 Symberix
11.16.1 Symberix Company Information
11.16.2 Symberix Microbiome Therapeutics Product Offered
11.16.3 Symberix Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Symberix Main Business Overview
11.16.5 Symberix Latest Developments
11.17 OpenBiome
11.17.1 OpenBiome Company Information
11.17.2 OpenBiome Microbiome Therapeutics Product Offered
11.17.3 OpenBiome Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 OpenBiome Main Business Overview
11.17.5 OpenBiome Latest Developments
11.18 Azitra
11.18.1 Azitra Company Information
11.18.2 Azitra Microbiome Therapeutics Product Offered
11.18.3 Azitra Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Azitra Main Business Overview
11.18.5 Azitra Latest Developments
11.19 Symbiotix Biotherapies
11.19.1 Symbiotix Biotherapies Company Information
11.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Offered
11.19.3 Symbiotix Biotherapies Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Symbiotix Biotherapies Main Business Overview
11.19.5 Symbiotix Biotherapies Latest Developments
11.20 Osel
11.20.1 Osel Company Information
11.20.2 Osel Microbiome Therapeutics Product Offered
11.20.3 Osel Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Osel Main Business Overview
11.20.5 Osel Latest Developments
11.21 Metabogen
11.21.1 Metabogen Company Information
11.21.2 Metabogen Microbiome Therapeutics Product Offered
11.21.3 Metabogen Microbiome Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Metabogen Main Business Overview
11.21.5 Metabogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. MicrobiomeTherapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. MicrobiomeTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Upper GIT
Table 4. Major Players of Lower GIT
Table 5. MicrobiomeTherapeutics Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 7. Global MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Table 8. MicrobiomeTherapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 10. Global MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Table 11. Global MicrobiomeTherapeutics Revenue by Player (2020-2025) & ($ millions)
Table 12. Global MicrobiomeTherapeutics Revenue Market Share by Player (2020-2025)
Table 13. MicrobiomeTherapeutics Key Players Head office and Products Offered
Table 14. MicrobiomeTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 18. Global MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Table 19. Global MicrobiomeTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global MicrobiomeTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas MicrobiomeTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas MicrobiomeTherapeutics Market Size Market Share by Country (2020-2025)
Table 23. Americas MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 24. Americas MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Table 25. Americas MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Table 27. APAC MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Table 29. APAC MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 30. APAC MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe MicrobiomeTherapeutics Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe MicrobiomeTherapeutics Market Size Market Share by Country (2020-2025)
Table 33. Europe MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 34. Europe MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa MicrobiomeTherapeutics Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa MicrobiomeTherapeutics Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa MicrobiomeTherapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of MicrobiomeTherapeutics
Table 39. Key Market Challenges & Risks of MicrobiomeTherapeutics
Table 40. Key IndustryTrends of MicrobiomeTherapeutics
Table 41. Global MicrobiomeTherapeutics Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global MicrobiomeTherapeutics Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global MicrobiomeTherapeutics Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global MicrobiomeTherapeutics Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. SeresTherapeutics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 46. SeresTherapeutics MicrobiomeTherapeutics Product Offered
Table 47. SeresTherapeutics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. SeresTherapeutics Main Business
Table 49. SeresTherapeutics Latest Developments
Table 50. Assembly Biosciences Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 51. Assembly Biosciences MicrobiomeTherapeutics Product Offered
Table 52. Assembly Biosciences MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Assembly Biosciences Main Business
Table 54. Assembly Biosciences Latest Developments
Table 55. Synthetic Biologics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 56. Synthetic Biologics MicrobiomeTherapeutics Product Offered
Table 57. Synthetic Biologics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Synthetic Biologics Main Business
Table 59. Synthetic Biologics Latest Developments
Table 60. Interxon Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 61. Interxon MicrobiomeTherapeutics Product Offered
Table 62. Interxon MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Interxon Main Business
Table 64. Interxon Latest Developments
Table 65. PureTech Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 66. PureTech MicrobiomeTherapeutics Product Offered
Table 67. PureTech MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. PureTech Main Business
Table 69. PureTech Latest Developments
Table 70. Synlogic Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 71. Synlogic MicrobiomeTherapeutics Product Offered
Table 72. Synlogic MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Synlogic Main Business
Table 74. Synlogic Latest Developments
Table 75. Enterome BioScience Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 76. Enterome BioScience MicrobiomeTherapeutics Product Offered
Table 77. Enterome BioScience MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Enterome BioScience Main Business
Table 79. Enterome BioScience Latest Developments
Table 80. 4D Pharma Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 81. 4D Pharma MicrobiomeTherapeutics Product Offered
Table 82. 4D Pharma MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. 4D Pharma Main Business
Table 84. 4D Pharma Latest Developments
Table 85. Second Genome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 86. Second Genome MicrobiomeTherapeutics Product Offered
Table 87. Second Genome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Second Genome Main Business
Table 89. Second Genome Latest Developments
Table 90. AOBiome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 91. AOBiome MicrobiomeTherapeutics Product Offered
Table 92. AOBiome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. AOBiome Main Business
Table 94. AOBiome Latest Developments
Table 95. C3 Jian Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 96. C3 Jian MicrobiomeTherapeutics Product Offered
Table 97. C3 Jian MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. C3 Jian Main Business
Table 99. C3 Jian Latest Developments
Table 100. Rebiotix Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 101. Rebiotix MicrobiomeTherapeutics Product Offered
Table 102. Rebiotix MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Rebiotix Main Business
Table 104. Rebiotix Latest Developments
Table 105. MicroBiomeTherapeutics LLC Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 106. MicroBiomeTherapeutics LLC MicrobiomeTherapeutics Product Offered
Table 107. MicroBiomeTherapeutics LLC MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. MicroBiomeTherapeutics LLC Main Business
Table 109. MicroBiomeTherapeutics LLC Latest Developments
Table 110. Metabiomics Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 111. Metabiomics MicrobiomeTherapeutics Product Offered
Table 112. Metabiomics MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Metabiomics Main Business
Table 114. Metabiomics Latest Developments
Table 115. Ritter Pharmaceuticals Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 116. Ritter Pharmaceuticals MicrobiomeTherapeutics Product Offered
Table 117. Ritter Pharmaceuticals MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Ritter Pharmaceuticals Main Business
Table 119. Ritter Pharmaceuticals Latest Developments
Table 120. Symberix Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 121. Symberix MicrobiomeTherapeutics Product Offered
Table 122. Symberix MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Symberix Main Business
Table 124. Symberix Latest Developments
Table 125. OpenBiome Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 126. OpenBiome MicrobiomeTherapeutics Product Offered
Table 127. OpenBiome MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. OpenBiome Main Business
Table 129. OpenBiome Latest Developments
Table 130. Azitra Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 131. Azitra MicrobiomeTherapeutics Product Offered
Table 132. Azitra MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Azitra Main Business
Table 134. Azitra Latest Developments
Table 135. Symbiotix Biotherapies Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 136. Symbiotix Biotherapies MicrobiomeTherapeutics Product Offered
Table 137. Symbiotix Biotherapies MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Symbiotix Biotherapies Main Business
Table 139. Symbiotix Biotherapies Latest Developments
Table 140. Osel Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 141. Osel MicrobiomeTherapeutics Product Offered
Table 142. Osel MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Osel Main Business
Table 144. Osel Latest Developments
Table 145. Metabogen Details, CompanyType, MicrobiomeTherapeutics Area Served and Its Competitors
Table 146. Metabogen MicrobiomeTherapeutics Product Offered
Table 147. Metabogen MicrobiomeTherapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Metabogen Main Business
Table 149. Metabogen Latest Developments
LIST OFFIGURES
Figure 1. MicrobiomeTherapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global MicrobiomeTherapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. MicrobiomeTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. MicrobiomeTherapeutics Sales Market Share by Country/Region (2024)
Figure 8. MicrobiomeTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global MicrobiomeTherapeutics Market Size Market Share byType in 2024
Figure 10. MicrobiomeTherapeutics in C. difficile Infection (CDI)
Figure 11. Global MicrobiomeTherapeutics Market: C. difficile Infection (CDI) (2020-2025) & ($ millions)
Figure 12. MicrobiomeTherapeutics in Inflammatory Bowel Disease (IBD)
Figure 13. Global MicrobiomeTherapeutics Market: Inflammatory Bowel Disease (IBD) (2020-2025) & ($ millions)
Figure 14. MicrobiomeTherapeutics in Orphan Drug
Figure 15. Global MicrobiomeTherapeutics Market: Orphan Drug (2020-2025) & ($ millions)
Figure 16. MicrobiomeTherapeutics in Immuno-oncology
Figure 17. Global MicrobiomeTherapeutics Market: Immuno-oncology (2020-2025) & ($ millions)
Figure 18. MicrobiomeTherapeutics in Others
Figure 19. Global MicrobiomeTherapeutics Market: Others (2020-2025) & ($ millions)
Figure 20. Global MicrobiomeTherapeutics Market Size Market Share by Application in 2024
Figure 21. Global MicrobiomeTherapeutics Revenue Market Share by Player in 2024
Figure 22. Global MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Figure 23. Americas MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 24. APAC MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 25. Europe MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa MicrobiomeTherapeutics Market Size 2020-2025 ($ millions)
Figure 27. Americas MicrobiomeTherapeutics Value Market Share by Country in 2024
Figure 28. United States MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC MicrobiomeTherapeutics Market Size Market Share by Region in 2024
Figure 33. APAC MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 34. APAC MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 35. China MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. India MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe MicrobiomeTherapeutics Market Size Market Share by Country in 2024
Figure 42. Europe MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 43. Europe MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 44. Germany MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45.France MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. UK MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share byType (2020-2025)
Figure 51. Middle East & Africa MicrobiomeTherapeutics Market Size Market Share by Application (2020-2025)
Figure 52. Egypt MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55.Turkey MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries MicrobiomeTherapeutics Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 58. APAC MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 59. Europe MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 61. United States MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 62. Canada MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 63. Mexico MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 64. Brazil MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 65. China MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 66. Japan MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 67. Korea MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 69. India MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 70. Australia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 71. Germany MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 72.France MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 73. UK MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 74. Italy MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 75. Russia MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 76. Egypt MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 77. South Africa MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 78. Israel MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 79.Turkey MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
Figure 80. Global MicrobiomeTherapeutics Market Size Market ShareForecast byType (2026-2031)
Figure 81. Global MicrobiomeTherapeutics Market Size Market ShareForecast by Application (2026-2031)
Figure 82. GCC Countries MicrobiomeTherapeutics Market Size 2026-2031 ($ millions)
More Publications
Global Neurological Biomarkers Market Growth 2025-2031
US$ 3,660.00
January 2025
134 pages
Global Injectable Cement Market Growth 2025-2031
US$ 3,660.00
December 2025
142 pages
Global Alfacalcidol Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
81 pages
Global Spinal Trauma Devices Market Growth 2025-2031
US$ 3,660.00
December 2024
126 pages
